Important recognition for Vismederi, which has ranked 72nd in the "Champions of Growth 2023" ranking list compiled by the German Institute for Quality and Finance (Itqf) and Repubblica's "Affari e Finanza." This is an important result that certifies Vismederi -...

VisMederi Pharma Srl and its new line of supplements have been officially presented this evening at the Volte di Vicobello location in Siena, in front of a large audience made up of local pharmacists and doctors operating on the territory.   “I am really proud...

This morning at the Auditorium of the Toscana Life Sciences Foundation, the company ETHS Srl, part of the VisMederi Group, received a visit from the students of Kent State University (USA) taking part in the "Florence Health Institute" (FHI) Program, thanks to an...

The VisMederi Group keeps growing: its companies closed 2021 budgets with turnovers of over 25 million Euros. This represents an important result, closing a year still deeply affected by Covid-19 and vaccinations. Other significant numbers: 20% trading profit, 37%...

Important new developments for VisMederi Life Sciences. One of the exclusive tests promoted, related to the evaluation of the anti-SARS-CoV-2 activity of appropriately treated fabrics and surfaces, has now also obtained Accredia accreditation, according to ISO...

VisMederi Srl took part into research on antibody and cellular response induced by mRna vaccine against Covid-19. This trial involved a group of 352 healthcare workers, 180 days after the second shot of Pfizer-Biontech mRna vaccine. VisMederi founder and CSO...